LGT Fund Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,600
Closed -$347K 151
2023
Q1
$347K Hold
1,600
0.15% 99
2022
Q4
$329K Hold
1,600
0.14% 89
2022
Q3
$445K Hold
1,600
0.21% 72
2022
Q2
$306K Hold
1,600
0.04% 152
2022
Q1
$333K Hold
1,600
0.04% 163
2021
Q4
$285K Buy
+1,600
New +$316K 0.08% 147

Other funds holding SWAV

LGT Fund Management's SWAV Position: Q2 2023 in Review

LGT Fund Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2023, closing a stake of 1,600 shares — an estimated $347K sold.

LGT Fund Management first reported a position in SWAV in Q4 2021 and held it in 6 quarters. The position peaked at $445K in Q3 2022. 460 funds tracked by Wall St. Rank hold SWAV as of Q2 2023.

  • LGT Fund Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • LGT Fund Management sold 1,600 Shockwave Medical, Inc. Common Stock shares in Q2 2023, an estimated $347K.
  • LGT Fund Management first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • LGT Fund Management's Shockwave Medical, Inc. Common Stock position peaked at $445K in Q3 2022.
  • 460 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2023.

Based on LGT Fund Management's 13F filing for Q2 2023, filed 27 Jul 2023.